← back to search

Josh Chen

Vertex Pharmaceuticals (United States) · US
Area of research
Statistics and Probability · Economics and Econometrics
Research interest
Research interests include Statistical Methods in Clinical Trials, Advanced Causal Inference Techniques, Health Systems, Economic Evaluations, Quality of Life, and Statistical Methods and Inference.
h-index
7
citations
953
works
17
NIH funding
primary concept
Medicine
email

Recent publications

Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial
The Lancet Infectious Diseases 2020cited by 75position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Guy de Bruyn · Sanofi (United States)1 papers (2020–2020)Carlos Fernando de Magalhães Francesconi · Universidade Federal do Rio Grande do Sul1 papers (2020–2020)Richard Gesser · Sanofi (United States)1 papers (2020–2020)David Gordon · National Health and Medical Research Council1 papers (2020–2020)Paul Anantharajah Tambyah · National University of Singapore1 papers (2020–2020)Thelma Laot · Taguig City University1 papers (2020–2020)Julián Torre‐Cisneros · Instituto de Salud Carlos III1 papers (2020–2020)Steve Self · Precision for Medicine (United States)1 papers (2020–2020)Ehab Bassily · Sanofi (United States)1 papers (2020–2020)Robert Jeanfreau · East Jefferson General Hospital1 papers (2020–2020)Ernesto Oviedo‐Orta · Regeneron (United States)1 papers (2020–2020)Odile Launay · Assistance Publique – Hôpitaux de Paris1 papers (2020–2020)Yoon Soo Park · Yonsei University1 papers (2020–2020)Dhaval M. Patel · Sanofi (United States)1 papers (2020–2020)Eng-Soon Chan · Sanofi (Canada)1 papers (2020–2020)Franco M. Piazza · Sanofi (Mexico)1 papers (2020–2020)Catherine Cosgrove · Northern General Hospital1 papers (2020–2020)Enrique Rivas · Sanofi (Mexico)1 papers (2020–2020)Sanjay Gurunathan · Sanofi (United States)1 papers (2020–2020)Theodore S. Steiner · University of British Columbia1 papers (2020–2020)